More earnings news, an update on GDP growth and key developments in Washington’s health-care debate will dominate investor attention in the week to come. MarketWatch’s Chris Noble reports from San Francisco.
More earnings news, an update on GDP growth and key developments in Washington’s health-care debate will dominate investor attention in the week to come. MarketWatch’s Chris Noble reports from San Francisco.
Discussion
View Comments for “U.S. Week Ahead”